Aug 28 (Reuters) – Eli Lilly said on Friday the U.S. FDA has approved its diabetes drug Mounjaro to lower the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high risk for these events.
(Reporting by Sneha S K; Editing by Shilpi Majumdar)
